MedCity News » medical devices

Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger

Allurion Technologies has developed a gastric balloon that does not require surgery. The merger deal taking Allurion public comes as the company continues global commercialization of its technology. The post Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger appeared first on MedCity News.

Feb 9, 2025 - 22:03
 0
Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger

Allurion Technologies has developed a gastric balloon that does not require surgery. The merger deal taking Allurion public comes as the company continues global commercialization of its technology.

The post Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC Merger appeared first on MedCity News.

Read More

Tags:

Previous Article

Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps

Next Article

Thermo Fisher lays off another 300 workers in Massachusetts

Related Posts

How Medicare Coverage Diversifies Access to Innovation

How Medicare Coverage Diversifies Access to Innovation

Feb 9, 2025  0

A New Dawn in Patient Empowerment is Upon Us

A New Dawn in Patient Empowerment is Upon Us

Feb 9, 2025  0

The Role of Proactive Monitoring Solutions in the Shift to a Risk-Based Care Model

The Role of Proactive Monitoring Solutions in the Shift...

Feb 9, 2025  0